Dr. Martina Diminić Smetiško, Managing Director
The drug development industry has been witnessing a massive transformation alongside the evolution of modern medicine and the rising demand for quality and affordable drugs. Against this changing backdrop, the vital role of contract research organizations (CROs) in helping pharma and biopharma firms address today’s complex drug development challenges has considerably grown over the past few years. Today, sponsors are increasingly engaging CROs to provide data-driven insights and navigate the changing drug development landscape for the next generation of medicines. However, even with the latest technologies to back their business initiatives, pharma firms need a reliable consulting partner that can support them in their health product’s life-cycle from development to regulatory compliance. This is where Marti Farm serves as a partner of choice through its exceptional range of consultancy and regulatory services across pharmacovigilance, cosmetovigilance, registration and market access, clinical trials, patient support programs, and medical writing.
Marti Farm is a fast-growing CRO employing more than 30 highly trained experts that have over 200 years of combined experience in the pharma industry. Dr. Martina Diminić Smetiško, Director, Marti Farm, says, “We encourage and implement new technologies, educational strategies and business models to improve day-to-day operations and the resultant satisfaction of our clients. We strive to offer our top-most skillset and experience to ease processes and projects.” Through extensive analysis, study and ensuring good risk assessment of regulations and compliance, Marti Farm prides itself in successfully predicting regulatory challenges of its clients beforehand.
The Marti Farm team has developed a fully validated and user-friendly pharmacovigilance safety database known as Sympto®
, which has been designed to improve case reporting, literature searching, and qualitative signal detection.
Sympto® is ideal for pharmacovigilance and cosmetovigilance and is integrated with European Medicines Agency and FDA gateway for factual reporting
Martina explains, “Through our vast experience, we realized that there are many clinical trial databases out in the market that are not user-friendly and do not provide resources that are essential for better preparation in audits, inspections and also to identify and minimize errors.” Sympto®
, on the other hand, is a fully validated and user-friendly product that is ideal for pharmacovigilance and cosmetovigilance, and is integrated with European Medicines Agency and FDA gateway for factual reporting. With the help of Sympto®
, Marti Farm effectively provides case processing and medical writing of documents such as DSURs, PSURs, and line listings that cover the safety summary of medicinal products during their clinical trials.
CROs are often unable to provide their clients with prompt and safe clinical resource management. A significant part of this limitation is due to the lack of staff, inadequate QMS system or lack of experience. With a primary goal to always put its clients first and dedicating a valuable amount of time and employees for client projects, Marti Farm ensures compliance, promptness, and correctness, all of which attribute for significant value addition for its clients.
Today, from a business standpoint, Marti Farm has already established its distinction with its ‘client first’ approach and treating them as a part of its family. “We currently have clients who have been with us since day one, and we have provided them our wholehearted dedication, the best team, and a warm touch of personalization,” remarks Martina.
The coming year will see the company expanding its footprint and working on two big projects in its pipeline. In the pursuit of these goals, Marti Farm plans to hire more experts and implement state of the art software for pharmacovigilance. Alongside conducting a couple of patient support programs, the company plans to grow beyond borders and garner reputation in the international markets for its unique value, precision, and services.